For weight loss, when you eat is far less important than hitting your overall calorie target
Synergistic Research Applications Retatrutide is frequently researched alongside complementary metabolic, recovery, and body-composition compounds due to its unique triple-receptor activity involving GLP-1, GIP, and glucagon pathways
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
These medications work by slowing gastric emptying and increasing feelings of fullness, which can lead to nausea as your body adapts to the new signals
Peptides 101 What exactly are peptides, and why do they matter
Microdosing operates below those initiation thresholds
